Rebalix
Xtrackers · sheet of 10 September 2026
Xtrackers · sheet of 10 September 2026ETF sheet · official issuer and register data
Xtrackers Msci Ac Asia Ex Japan Esg Swap UCITS ETF 1c
LU0322252171 · LU0322252171 · USD · domicile Luxembourg
Equity · Asia-Pacific · Sustainable / ESGSFDR art. 8
Index tracked: MSCI AC Asia ex Japan Low Carbon SRI Selection Capped Index (USD)
- TER
- 0.65%+ trans. 0.00%
- Fund size
- 307 m EUR
- Tracking difference
- −0.69%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 20 Jan 2009 · costs from the KID as of 2 Sept 2026 · 81 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance of the MSCI AC Asia ex Japan Low Carbon SRI Selection Capped Index (index).
DESCRIPTION OF INDEX:
The index is based on the MSCI AC Asia ex Japan Index (Parent Index), which is designed to reflect the performance of certain large and medium capitalisation companies from developed and emerging markets in Asia (excluding Japan). In order to be eligible for inclusion in the index, companies must be eligible for inclusion in the Parent Index and…
Performance since series start (in euro) — base 100
20 Jan 2009 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +5.6% |
| 3 years | +31.8% |
| 5 years | +5.5% |
| 10 years | +63.6% |
| Since series start | +347.5% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 21.26% | 19.14% | 19.79% |
| Max drawdown | −13.67% | −16.69% | −38.86% |
| Sharpe | 0.18 | 0.54 | 0.01 |
| Sortino | 0.26 | 0.77 | 0.02 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU0322252171 · LU03222521711
RebalixLU0322252171 · LU0322252171 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +29.01% | +29.78% | −0.78% |
| 2024 | +9.13% | +9.81% | −0.68% |
| 2023 | −2.58% | −1.96% | −0.62% |
| 2022 | −20.05% | −17.29% | −2.76% |
| 2021 | −5.31% | −4.72% | −0.60% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 2 Sept 2026 · 81 securities · top-10 weight = 33.9%
| Top holdings | Weight |
|---|---|
| 4.9% | |
| 4.5% | |
| 3.8% | |
| 3.8% | |
| 3.7% | |
| 3.7% | |
| 2.6% | |
| 2.4% | |
| 2.4% | |
| 2.3% |
Listing venues
ESMA register (FIRDS) and official exchange lists
XAXJ · Borsa Italiana (ETFplus), Xetra (Deutsche Börse)
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
+ 24 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU0322252171
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU0322252171
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · LU0322252171 · LU03222521712